Hongmeng Su
The Key Laboratory Of Developmental Genes And Human Diseases
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identification of ETV5 as a prognostic marker related to epigenetic modification in pan-cancer and facilitates tumor progression in hepatocellular carcinoma.
Journal: Scientific reports
Published: June 14, 2024
Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Journal: Investigational new drugs
Published: December 15, 2023
Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer.
Journal: Scientific reports
Published: October 07, 2023
ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
Journal: Biochemical and biophysical research communications
Published: August 31, 2023
Suppression of NSUN2 enhances the sensitivity to chemosensitivity and inhibits proliferation by mediating cell apoptosis in gastric cancer.
Journal: Pathology, research and practice
Published: June 11, 2023
Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma.
Journal: Biomarkers in medicine
Published: February 25, 2022
TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 03, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026